Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity

Not yet recruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
HPV InfectionHPV VaccineCervical Cancer Prevention
Interventions
OTHER

Follow up

Each subject was recruited in 30-60 days after the last dose of domestic bivalent HPV vaccine or imported HPV vaccine, and followed up at 12 months (window period ± 1 month) and 36 months (window period ± 1 month) after the last dose of domestic bivalent HPV vaccine or imported HPV vaccine, with a total of two follow-up visits. At enrollment and both follow-up visits, subjects were required to collect 2 tubes of peripheral venous blood each.

Trial Locations (1)

350001

Fujian Maternity and Child Health Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Maternity and Child Health Hospital

OTHER

NCT06137352 - Two Domestic HPV Vaccines and Imported HPV Vaccines in Women Aged 13-14 Years Study on Immunogenicity | Biotech Hunter | Biotech Hunter